Sen. Hassan Leads Push for an Investigation Into McKinsey's Potential Conflicts of Interest in Relation to Opioid Crisis
April 06, 2022
April 06, 2022
WASHINGTON, April 6 -- Sen. Maggie Hassan, D-New Hampshire, issued the following news release:
U.S. Senator Maggie Hassan (D-NH), Chair of the Emerging Threats and Spending Oversight Subcommittee, led a group of her colleagues in calling for an investigation into the failure of the consulting firm McKinsey & Company to disclose potential conflicts of interest when the company was simultaneously working with the Food and Drug Administration (FDA) on issues related to opioids and . . .
U.S. Senator Maggie Hassan (D-NH), Chair of the Emerging Threats and Spending Oversight Subcommittee, led a group of her colleagues in calling for an investigation into the failure of the consulting firm McKinsey & Company to disclose potential conflicts of interest when the company was simultaneously working with the Food and Drug Administration (FDA) on issues related to opioids and . . .